chevron_leftBack
As of 14 June 2026, Avoca LLC has a market cap of $10.27M USD, ranking #41145 globally and #5318 in the United States.
It ranks #3657 in the Healthcare sector, and #247 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$10.27MUSD
Revenue (TTM)
$5.02MUSD
EBITDA (TTM)
$4.66MUSD
Net Income (TTM)
$3.25MUSD
EBITDA Margin
93%
Profit Margin
65%
PE Ratio
3.2
PS Ratio
2.0
PB Ratio
1.7
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 11% | -20% | -12% | -6.7% | -18% | -8% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
AVOA
ISIN: US0538432073
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1,275.00 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Avoca LLC
Avoca LLC operates as a subsidiary of Hancock Whitney Bank.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
288K%
|
-
|
|
LSE: INDV
|
$2.07B
20K%
1.54B GBP
|
-
|
|
OTCMKTS: NDOI
|
$1.8B
17K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
17K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
13K%
|
-
|
|
NYSE: BRBR
|
$1.02B
10K%
|
12.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.75B
358K%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.84B
154K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
109K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
107K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
88K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.74B
85K%
7.57B EUR
|
-
|
chevron_leftBack